Notably, treatment regimens combining anti‐PD‐1 with Eudoraea can activate CD8+ T cell and NKT cell functions, significantly enhancing the efficacy of immunotherapy in mouse tumor models [179]. The gene discussed is CD8A; the disease is neoplasm.